(Q39293912)

10 September 2017

title

Formulations of fentanyl for the management of pain (English)

1 reference

10 September 2017

0 references

0 references

Stephan A Schug

2

0 references

author name string

Sina Grape

series ordinal

1

1 reference

10 September 2017

Stefan Lauer

series ordinal

3

1 reference

10 September 2017

Barbara S Schug

series ordinal

4

1 reference

10 September 2017

publication date

1 January 2010

1 reference

10 September 2017

1 reference

10 September 2017

volume

70

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

57-72

1 reference

Characterisation of the pharmacokinetics of the fentanyl HCl patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing and comparison with IV fentanyl administration.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11531740-000000000-00000

Evaluation of diurnal variation in fentanyl clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11531740-000000000-00000

Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11531740-000000000-00000

Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11531740-000000000-00000

Fentanyl transdermal system overdose secondary to cutaneous hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11531740-000000000-00000

An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study

21 January 2018

1 reference

12 December 2020

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

1 reference

12 December 2020

Guidelines for the clinical use of transdermal fentanyl

1 reference

12 December 2020

Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.

1 reference

12 December 2020

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

1 reference

12 December 2020

A randomized controlled trial of intranasal fentanyl vs intravenous morphine for analgesia in the prehospital setting.

1 reference

12 December 2020

Intranasal fentanyl for postoperative analgesia after elective Caesarean section

1 reference

12 December 2020

A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects.

1 reference

12 December 2020

Practice guidelines for transdermal opioids in malignant pain

1 reference

12 December 2020

Transdermal fentanyl: acute analgesic clinical studies

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers

1 reference

12 December 2020

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).

1 reference

12 December 2020

Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case series

1 reference

12 December 2020

Pharmacokinetics of inhaled liposome-encapsulated fentanyl.

1 reference

12 December 2020

Intranasal fentanyl provides adequate postoperative analgesia in pediatric patients

1 reference

12 December 2020

Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applications

1 reference

12 December 2020

Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers

1 reference

12 December 2020

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

1 reference

12 December 2020

Pain--final common pathways: pathophysiology and pragmatism

1 reference

12 December 2020

A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department

1 reference

12 December 2020

In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance

1 reference

12 December 2020

Absorption characteristics of transdermally administered fentanyl

1 reference

12 December 2020

1 reference

12 December 2020

Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.

1 reference

12 December 2020

The safety and efficacy of fentanyl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management: an analysis of pooled data from three randomized, active-controlled clinical stud

1 reference

12 December 2020

Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study

1 reference

12 December 2020

Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study

1 reference

12 December 2020

Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates

1 reference

12 December 2020

Transdermal fentanyl in cachectic cancer patients.

1 reference

12 December 2020

Self-treatment with oral transmucosal fentanyl citrate to prevent emergency room visits for pain crises: patient self-reports of efficacy and utility

1 reference

12 December 2020

Breakthrough pain: definition, prevalence and characteristics

1 reference

12 December 2020

Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief

1 reference

12 December 2020

Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate

1 reference

12 December 2020

Impact of transdermal fentanyl on quality of life in rheumatoid arthritis

1 reference

12 December 2020

Intranasal fentanyl for breakthrough cancer pain. A pilot study

1 reference

12 December 2020

Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics.

1 reference

12 December 2020

Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy

1 reference

12 December 2020

Absorption and Bioavailability of Oral Transmucosal Fentanyl Citrate

1 reference

12 December 2020

Fentanyl remaining in a transdermal system following three days of continuous use.

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice

1 reference

12 December 2020

Transdermal fentanyl disposition in elderly subjects.

1 reference

12 December 2020

Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain

1 reference

12 December 2020

Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.

1 reference

12 December 2020

Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

System functionality and physicochemical model of fentanyl transdermal system.

1 reference

12 December 2020

Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery

1 reference

12 December 2020

A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns

1 reference

12 December 2020

Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine

1 reference

12 December 2020

Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series

1 reference

12 December 2020

Outpatient management of sickle cell pain with chronic opioid pharmacotherapy.

1 reference

12 December 2020

Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in

1 reference

12 December 2020

Problems of sweating and transdermal fentanyl.

1 reference

12 December 2020

Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control

1 reference

12 December 2020

Breakthrough pain: characteristics and impact in patients with cancer pain.

1 reference

12 December 2020

Postoperative pain management by intranasal demand-adapted fentanyl titration.

1 reference

12 December 2020

Opioids for the management of breakthrough (episodic) pain in cancer patients

1 reference

12 December 2020

Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain

1 reference

12 December 2020

The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain

1 reference

12 December 2020

[Pharmacokinetics of intranasal Fentanyl.].

1 reference

12 December 2020

The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects

1 reference

12 December 2020

The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat

1 reference

12 December 2020

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

1 reference

12 December 2020

A review of the use of fentanyl analgesia in the management of acute pain in adults

1 reference

12 December 2020

A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study

1 reference

12 December 2020

Clinical pharmacokinetics of fentanyl and its newer derivatives.

1 reference

12 December 2020

Transdermal fentanyl in cancer pain: conversion from oral morphine.

1 reference

12 December 2020

Characterization of breakthrough pain by hospice patients and their caregivers

1 reference

12 December 2020

Transdermal fentanyl: clinical pharmacology.

1 reference

12 December 2020

Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl

1 reference

12 December 2020

An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain

1 reference

12 December 2020

Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.

1 reference

12 December 2020

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

1 reference

12 December 2020

Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective, multicenter pilot study in outpatients with chronic pain.

1 reference

12 December 2020

Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients

1 reference

12 December 2020

Breakthrough pain in cancer patients: pathophysiology and treatment

1 reference

12 December 2020

Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors

1 reference

12 December 2020

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey.

1 reference

12 December 2020

A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care

1 reference

12 December 2020

A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia.

1 reference

12 December 2020

Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients.

1 reference

12 December 2020

The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial

1 reference

12 December 2020

A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer

1 reference

12 December 2020

Patient-controlled intranasal analgesia: a method for noninvasive postoperative pain management

1 reference

12 December 2020

Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study

1 reference

12 December 2020

Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl

1 reference

12 December 2020

Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil

1 reference

12 December 2020

Active transport of fentanyl by the blood-brain barrier.

1 reference

12 December 2020

Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states

1 reference

12 December 2020

Inhaled fentanyl as a method of analgesia

1 reference

12 December 2020

10.2165/11531740-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

10 September 2017

1039142219

0 references

1 reference